| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/16/2011 | EP2294202A1 Soluble recombinant influenza antigens |
| 03/16/2011 | EP2294184A1 Treatment of eye diseases and excessive neovascularization using a combined therapy |
| 03/16/2011 | EP2294089A2 Anti-fn14 antibodies and uses thereof |
| 03/16/2011 | EP2294087A1 Anti-hepcidin antibodies and methods of use |
| 03/16/2011 | EP2294086A2 Anti-inflammatory agents |
| 03/16/2011 | EP2294082A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 03/16/2011 | EP2294081A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
| 03/16/2011 | EP2294078A1 Rift valley fever virus-like particles and their use for immunization and as test system |
| 03/16/2011 | EP2293816A1 Methods for the treatment of rheumatoid arthritis |
| 03/16/2011 | EP2293815A1 Synergistic immunogenic fusion protein-polysaccharide conjugate |
| 03/16/2011 | EP2293814A2 Nanoemulsion adjuvants |
| 03/16/2011 | EP2293813A2 Nanoemulsion vaccines |
| 03/16/2011 | EP2293812A1 Method for isolating cells and disease vectors from bodily fluids |
| 03/16/2011 | EP2293810A2 Compositions and methods for preventing or treating aids |
| 03/16/2011 | EP2293667A2 Interleukin 10 receptor (il-10r) antibodies and methods of use |
| 03/16/2011 | EP2102345B1 Rsv f-protein and use thereof |
| 03/16/2011 | EP2097453B1 Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii) |
| 03/16/2011 | EP1917976B1 Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration |
| 03/16/2011 | EP1833507B1 Compositions for immunizing against mycobacterium |
| 03/16/2011 | EP1812046B1 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 03/16/2011 | EP1641926B1 Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases |
| 03/16/2011 | EP1551876B1 Antibodies that bind cell-associated ca 125/0722p and methods of use thereof |
| 03/16/2011 | EP1412388B1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 03/16/2011 | EP1383785B1 Recombinant tumor specific antibody and use thereof |
| 03/16/2011 | EP1359938B1 Method for treating psoriasis by using an il-17d antagonist |
| 03/16/2011 | EP1326633B1 Composition comprising immunogenic microparticles |
| 03/16/2011 | CN1953767B Regulatory T cells suppress autoimmunity |
| 03/16/2011 | CN101986783A Anti-MDL-1 antibodies |
| 03/16/2011 | CN101985468A SJ16 recombinant protein and application thereof in preparing schistosomiasis vaccine, diagnostic reagent and therapeutic drug |
| 03/16/2011 | CN101985037A Applications of receptor for activated C-kinase 1 as target against tumor drug-resistance |
| 03/16/2011 | CN101985036A Amyloid- beta (1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof |
| 03/16/2011 | CN101362796B B cell epitope of epididymal protease inhibitor and multiple antigenic peptide containing thereof |
| 03/16/2011 | CN101357228B Preparation method of hepatitis b human immunoglobulin for intravenous injection |
| 03/15/2011 | US7906629 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/15/2011 | US7906626 using bispecific antibodies comprising an antibody having binding specificity which confers the ability to cross the blood-brain barrier, and a second antibody conferring the ability to bind to beta -amyloid epitopes, used for the treatment of Alzheimer's disease or Down's syndrome |
| 03/15/2011 | US7906621 Anti-tumor drug, medicament, composition, and use thereof |
| 03/15/2011 | US7906620 Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| 03/15/2011 | US7906481 Using tumor necrosis factor inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders |
| 03/15/2011 | US7906329 Transgenic cells expressing anti-human squamous-cell carcinoma monoclonal antibody with enhanced antibody dependent cellular cytotoxicity (ADCC); drug targeting and delivery |
| 03/15/2011 | US7906311 For production of viruses causing porcine reproductive and respiratory syndrome (PRRS) |
| 03/15/2011 | US7906308 Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex |
| 03/15/2011 | US7906292 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| 03/15/2011 | US7906277 Compound and methods for diagnosis of tuberculosis |
| 03/15/2011 | US7906124 Inactivation of smooth muscle tissue |
| 03/15/2011 | US7906123 Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof |
| 03/15/2011 | US7906122 Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination |
| 03/15/2011 | US7906121 Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| 03/15/2011 | US7906120 Neurite outgrowth inhibitor -66 receptor (NOGO-66) specific monoclonal antibody for treatment and prevention of nervous system, muscular, tumor and vision disorders |
| 03/15/2011 | US7906119 Antibodies against protective antigen |
| 03/15/2011 | US7906118 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology |
| 03/15/2011 | US7906117 Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever |
| 03/15/2011 | US7906116 Methods for using and identifying modulators of Delta-like 4 |
| 03/15/2011 | US7906115 Antitumor, anticancer agents; complexing of phosphatides and antibodies |
| 03/15/2011 | CA2675757C Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 03/15/2011 | CA2608630C Polysaccharide extract of dendrobii herba and use thereof for treating autoimmune uveitis |
| 03/15/2011 | CA2489123C Use of a clathrate modifier to promote passage of proteins during nanofiltration |
| 03/15/2011 | CA2452005C Inhibition of apoptosis process and improvement of cell performance |
| 03/15/2011 | CA2433806C Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 03/15/2011 | CA2429134C A method for generating genetically altered antigens |
| 03/15/2011 | CA2410297C Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 03/15/2011 | CA2389302C Delivery of proteins across polar epithelial cell layers |
| 03/15/2011 | CA2380833C Proteins derived from white spot syndrome virus and uses thereof |
| 03/15/2011 | CA2374398C Immunoconjugates having high binding affinity |
| 03/15/2011 | CA2338982C Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 03/15/2011 | CA2188422C Bifunctional protein, preparation and use |
| 03/15/2011 | CA2184132C An adjuvanted vaccine which is substantially free of non-host albumin |
| 03/15/2011 | CA2163517C Surrogate tolerogenesis for the development of tolerance to xenografts |
| 03/11/2011 | CA2772929A1 Methods for treating, diagnosing, and monitoring rheumatoid arthritis |
| 03/10/2011 | WO2011028963A2 Immunogenic hiv composition |
| 03/10/2011 | WO2011028962A1 Antibody coformulations |
| 03/10/2011 | WO2011028961A2 Anti-botulism antibody coformulations |
| 03/10/2011 | WO2011028938A1 Methods for lowering serum cholestrol in a subject using inhibition of pcsk9 |
| 03/10/2011 | WO2011028888A2 Methods of reducing virucidal activity in pcv-2 compositions and pcv-2 compositions with an improved immunogenicity |
| 03/10/2011 | WO2011028875A1 Immunogenic conjugates for producing immune responses to drugs of abuse and methods of use |
| 03/10/2011 | WO2011028811A2 Dual variable domain immunoglobulins and uses thereof |
| 03/10/2011 | WO2011028652A1 Heterlogous prime-boost immunization regimen against bluetongue virus |
| 03/10/2011 | WO2011028390A1 Compositions and methods for potentiating interleukin-35 |
| 03/10/2011 | WO2011028371A1 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin |
| 03/10/2011 | WO2011028064A2 Novel bacteriophage and antibacterial composition comprising the same |
| 03/10/2011 | WO2011028061A2 Novel bacteriophage and antibacterial composition comprising the same |
| 03/10/2011 | WO2011028059A2 Novel bacteriophage and antibacterial composition comprising the same |
| 03/10/2011 | WO2011028057A2 Novel bacteriophage and antibacterial composition comprising the same |
| 03/10/2011 | WO2011027990A2 Extracellular vesicles derived from gram-positive bacteria, and use thereof |
| 03/10/2011 | WO2011027956A2 Extracellular vesicles derived from gram-positive bacteria, and disease model using same |
| 03/10/2011 | WO2011027349A1 Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof |
| 03/10/2011 | WO2011027222A2 Immunogenic compositions including tlr activity modulators |
| 03/10/2011 | WO2011027132A1 Clec14a inhibitors |
| 03/10/2011 | WO2011027116A1 Protein glycosylation |
| 03/10/2011 | WO2011026966A2 Method of treating eosinophilic esophagitis |
| 03/10/2011 | WO2011026882A1 Bovine herpesvirus vaccine |
| 03/10/2011 | WO2011026242A1 Monoclonal antibodies against gonadotropin-releasing hormone receptor |
| 03/10/2011 | WO2011026206A1 Isolated nucleic acid sequence, expression vector, synergistic immunogenic composition comprising an expression vector that codes for the e7 protein of human papilloma virus (hpv) fused with the gd-protein of human herpes virus type-1 (hsv-1), and an expression vector that codes for a cytokyne, and uses thereof |
| 03/10/2011 | WO2011000860A3 Human polypeptides that interact with hiv and htlv proteins |
| 03/10/2011 | WO2010149743A3 Vaccine |
| 03/10/2011 | WO2010148511A8 Chimeric influenza virus-like particles comprising hemagglutinin |
| 03/10/2011 | WO2010132389A3 Methods for treating cancers and diseases associated with 4-1bb (cd137) expression |
| 03/10/2011 | WO2010129947A3 Alpha thymosin peptides as vaccine enhancers |
| 03/10/2011 | WO2010127180A3 Dc-stamp antibodies |
| 03/10/2011 | WO2010127166A3 Combination anti-hiv vectors, targeting vectors, and methods of use |
| 03/10/2011 | WO2010126279A3 Cytokeratin 17-specific human antibody |